We are live on
!
Find out more
HWM
HighMark Wealth Management Portfolio holdings
AUM
$246M
1-Year Est. Return
35.95%
This Fund
S&P 500
This Quarter
Est. Return
-2.2%
1 Year Est. Return
+35.95%
3 Year Est. Return
+84.22%
5 Year Est. Return
+86.67%
10 Year Est. Return
–
AUM
$169M
AUM Growth
-$4.66M
(-2.7%)
Cap. Flow
+$2.74M
Cap. Flow
% of AUM
1.62%
Top 10 Holdings %
Top 10 Hldgs %
73.61%
Holding
610
New
35
Increased
156
Reduced
72
Closed
36
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AnaptysBio
ANAB
|
+$1.53M |
| 2 |
CNTA
Centessa Pharmaceuticals
CNTA
|
+$1.14M |
| 3 |
Axogen
AXGN
|
+$586K |
| 4 |
Tesla
TSLA
|
+$504K |
| 5 |
Pliant Therapeutics
PLRX
|
+$501K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FNA
Paragon 28, Inc.
FNA
|
+$1.36M |
| 2 |
NVIDIA
NVDA
|
+$517K |
| 3 |
iShares MSCI EAFE Value ETF
EFV
|
+$409K |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$252K |
| 5 |
PYCR
Paycor HCM, Inc. Common Stock
PYCR
|
+$144K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.33% |
| 2 | Financials | 5.86% |
| 3 | Technology | 3.53% |
| 4 | Industrials | 1.51% |
| 5 | Consumer Discretionary | 1.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
TELA Bio
TELA
$32.7M
| – | – |
-2,800
| Closed | -$8.46K |
|
602
Targa Resources
TRGP
$58B
| – | – |
-17
| Closed | -$3.04K |
|
|
PYCR
603
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
| – | – |
-7,730
| Closed | -$144K |
|
|
CUTR
604
DELISTED
Cutera, Inc.
CUTR
| – | – |
-316
| Closed | -$112 |
|
|
MTTR
605
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| – | – |
-100
| Closed | -$474 |
|
|
NKLA
606
DELISTED
Nikola Corporation Common Stock
NKLA
| – | – |
-20
| Closed | -$24 |
|
|
ROIC
607
DELISTED
Retail Opportunity Investments Corp.
ROIC
| – | – |
-159
| Closed | -$2.76K |
|
|
ENLC
608
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| – | – |
-52
| Closed | -$736 |
|
|
AVGR
609
DELISTED
Avinger, Inc. Common Stock
AVGR
| – | – |
-127
| Closed | -$104 |
|
Similar funds
IRP
EPIM
MAMHA
CSC
NTCM
VPA
KC
HA
HighMark Wealth Management's Q1 2025 Portfolio in Review
As of Q1 2025, HighMark Wealth Management held 610 positions worth $169M, down 2.7% from $174M the previous quarter. Its ten largest holdings account for 74% of the portfolio.
HighMark Wealth Management's Q1 2025 filing shows 35 new, 156 increased, 72 reduced and 36 closed positions. Its largest new stake was AnaptysBio: 92,000 shares worth $1.71M. The largest sale was Paragon 28, Inc., an estimated $1.36M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Financials and Technology.
- HighMark Wealth Management's largest Q1 2025 buy was AnaptysBio: 92,000 shares worth $1.71M.
- HighMark Wealth Management added most to Centessa Pharmaceuticals in Q1 2025, an estimated $1.14M increase.
- HighMark Wealth Management's biggest Q1 2025 reduction was Paragon 28, Inc., cutting an estimated $1.36M.
- HighMark Wealth Management fully exited Paycor HCM, Inc. Common Stock in Q1 2025, selling an estimated $144K.
- HighMark Wealth Management's ten largest holdings make up 74% of its $169M portfolio in Q1 2025.
- HighMark Wealth Management opened 35 new positions and closed 36 in Q1 2025.
- HighMark Wealth Management's portfolio value fell 2.7% quarter-over-quarter to $169M.
Based on HighMark Wealth Management's 13F filing for Q1 2025, filed 24 Apr 2025.